Late infectious complications after CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy for large B-cell lymphomas (LCBL): Real-world predictors and outcomes.
Daniel E. Goyco Vera, Omer Abdrabbuh, Fatima Massare Somers, Song Zhang et autres
us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology